Concepedia

Takahiro Ishiguro

TI

Statistics

Publications

34

Citations

1.4K

H-Index

22

Active since

1998

Affiliations

Chugai Pharma (United States)(Current)

Nagoya University

Iwate University

The University of Tokyo

University of Miyazaki

Takahiro Ishiguro is an author at Chugai Pharma (United States) specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1998–2022

34

Publications

34

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 203 citations

Medicine, Oncology, Pharmacology +15

Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Takahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita et al. · Cancer Research · 2008 · 176 citations

Medicine, Oncology, Pharmacology +12

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

Kiyotaka Nakano, Tetsuro Orita, Jun‐ichi Nezu et al. · Biochemical and Biophysical Research Communications · 2008 · 111 citations

Medicine, Oncology, Pharmacology +14

Circulating biomarkers in hepatocellular carcinoma

Karen Morris, Jonathan Tugwood, Leila Khoja et al. · Cancer Chemotherapy and Pharmacology · 2014 · 68 citations

Medicine, Cancer Biology, Oncology +12

Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma

H. TAKAI, Motohki Ashihara, Takahiro Ishiguro et al. · Cancer Biology & Therapy · 2009 · 68 citations · Full text

Life Sciences, Cell Biology, Oncology +17

1–5 of 34